Anbacim

Anbacim

cefuroxime

Manufacturer:

Sanbe
Concise Prescribing Info
Contents
Cefuroxime (Caplet: Axetil; inj: Na)
Indications/Uses
Infection of lower resp tract, urinary tract, soft tissue, bone & joint, O & G infection, gonorrhoea, septicaemia & meningitis. Prophylaxis against infection in abdominal, pelvic, orthopaedic, cardiac, pulmonary, esophageal & vascular surgery when there is increased risk from infection.
Dosage/Direction for Use
Caplet Adult & childn >12 yr 250 mg 2 times daily, may be increased up to 500 mg 2 times daily. Infant & childn ≤12 yr 125 mg 2 times daily. Uncomplicated UTI 125-250 mg 2 times daily. Uncomplicated gonococcal urethritis 1 g as a single dose. Otitis media Childn ≥2 yr 250 mg, <2 yr 125 mg. To be taken 2 times daily. Inj Adult 750 mg-1.5 g 8 hrly IM or IV for 5-10 days. If necessary, may increase to 3-6 g/day 6 hrly. Childn & infant >3 mth 50-100 mg/kg/day 6-8 hrly, severe & serious infections: 100 mg/kg/day. Bone & joint infections 150 mg/kg/day 8 hrly (not exceeding max dosage of adult). Bacterial meningitis 200-240 mg/kg/day IV 6-8 hrly.
Administration
Should be taken with food.
Contraindications
Hypersensitivity to cephalosporins.
Special Precautions
Anaphylactic reaction to penicillins; concurrent treatment w/ potent diuretics. Renal dysfunction.
Adverse Reactions
Hypersensitivity, GI disturbances including very rarely pseudomembranous colitis. Haematological changes. Occasionally, thrombophlebitis (IV inj).
Drug Interactions
Combination w/ aminoglycosides can increase nephrotoxicity.
MIMS Class
Cephalosporins
ATC Classification
J01DC02 - cefuroxime ; Belongs to the class of second-generation cephalosporins. Used in the systemic treatment of infections.
Presentation/Packing
Form
Anbacim FC caplet 500 mg
Packing/Price
5 × 4's (Rp442,000/boks)
Form
Anbacim powd for inj 1 g
Packing/Price
(vial) 1's (Rp80,550/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in